Abbott Laboratories (ABT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2005 | 09-2005 | 06-2005 | 03-2005 | 12-2004 | |
| Sales | 6,047,333 | 5,383,995 | 5,523,800 | 5,382,679 | 5,654,443 |
| Cost of Goods | 2,809,557 | 2,677,188 | 2,631,835 | 2,522,531 | 2,627,094 |
| Gross Profit | 3,237,778 | 2,706,807 | 2,891,965 | 2,860,148 | 3,027,348 |
| Operating Expenses | 1,937,532 | 1,876,315 | 1,797,885 | 1,724,808 | 1,898,257 |
| Operating Income | 1,300,802 | 830,680 | 1,094,915 | 1,135,871 | 1,129,186 |
| Interest Expense | 27,788 | 40,360 | 43,244 | 42,270 | 42,044 |
| Other Income | 126,910 | 105,350 | 94,799 | 84,255 | 68,502 |
| Pre-tax Income | 1,399,924 | 895,670 | 1,146,470 | 1,177,856 | 1,155,644 |
| Income Tax | 423,508 | 214,961 | 269,418 | 339,968 | 181,040 |
| Net Income Continuous | 976,416 | 680,709 | 877,052 | 837,888 | 974,604 |
| Net Income Discontinuous | N/A | N/A | N/A | N/A | 1 |
| Net Income | $976,416 | $680,709 | $877,052 | $837,888 | $974,605 |
| EPS Basic Total Ops | 0.63 | 0.44 | 0.56 | 0.54 | 0.61 |
| EPS Basic Continuous Ops | 0.63 | 0.44 | 0.56 | 0.54 | 0.61 |
| EPS Diluted Total Ops | 0.63 | 0.44 | 0.56 | 0.53 | 0.63 |
| EPS Diluted Continuous Ops | 0.63 | 0.44 | 0.56 | 0.53 | 0.63 |
| EBITDA(a) | $1,638,517 | $1,174,047 | $1,427,892 | $1,480,751 | $1,462,546 |